Companies: 10,795·Total market cap: $144.5T
Boston Therapeutics, Inc.

Boston Therapeutics, Inc.

BTHEOTCHealthcare
$0.01
+$0.00(+0.00%)
Market Cap$0
P/E Ratio—
52W High$0.0119
52W Low$0.0091
Overview

Boston Therapeutics, Inc. (BTHE) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · BTHE · as of Apr 7, 2023

Latest filing snapshot

30
+5+20.00%vs prior year

Boston Therapeutics, Inc. (BTHE) employee data is sourced from the annual SEC 10-K filing. As of 2022, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2022-12-31·Full-time · Global
Total Employees
30
Change (1Y)
+5
Growth % (1Y)
+20.00%
Revenue / Employee
$311
Net Income / Employee
$-30.3K
Market Cap
$0M

BTHE Employee Count

2010 – 2022 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2023-04-0730+5+20.00%
2022-04-1225+25—
2021-04-230+0—
2020-06-080-1-100.00%
2019-04-161-1-50.00%
2018-03-272+2—
2017-03-280+0—
2016-03-300-7-100.00%
2015-03-277-1-12.50%
2014-03-148+3+60.00%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
HealthBeacon plc
HBCNF
HealthBeacon plc
70
#2
Boston Therapeutics, Inc.
BTHE
Boston Therapeutics, Inc.YOU
30
#3
Avecho Biotechnology Limited
AVEFF
Avecho Biotechnology Limited
15
#4
Forward Pharma A/S
FWPAY
Forward Pharma A/S
4
#5
Bionomics Limited
BNOEF
Bionomics Limited
N/A
#6
The Flowr Corporation
FLWPF
The Flowr Corporation
N/A
#7
Immune Therapeutics, Inc.
IMUN
Immune Therapeutics, Inc.
N/A
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · BTHE peer comparison

About BTHE employees

BTHE Employees · Headcount

Boston Therapeutics, Inc. (BTHE) employee data is sourced from the annual SEC 10-K filing. As of 2022, Boston Therapeutics, Inc. had 30 full-time employees globally. Full-time employees only. Global consolidated headcount.

Boston Therapeutics, Inc. employs 30 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $311, reflecting the company's operational efficiency.

Boston Therapeutics, Inc.'s workforce increased by 5 (20.00%) in 2022 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Boston Therapeutics, Inc.'s revenue per employee of $311 positions it among the notable performers in the Biotechnology sector for operational efficiency.

RevenueFinancial statementsNet incomeSEC filingsPrice historyForecast & ratingsOwnershipEarnings

Frequently Asked Questions

BTHE Employees · 5 questions

As of the latest SEC 10-K filing (2022), Boston Therapeutics, Inc. had 30 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Boston Therapeutics, Inc. employee counthow many employees does Boston Therapeutics, Inc. haveBTHE total employees 2022

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2023-04-07